Acuamark Diagnostics
Christopher Mason is the Associate Professor Computational Genomics in Computational Biomedicine at Weill Cornell Medicine Institute for Computational Biomedicine with appointments at Department of Physiology,Biophysics and System Biology,, Meyer Cancer Center, Feil Family Brain and Mind Research Institute. Director, WorldQuant Initiative for Quantitative Prediction and WorldQuant Foundation Research Scholar. Affiliate Fellow of Genomics, Ethics, and Law, ISP, Yale Law School.
This person is not in the org chart
Acuamark Diagnostics
Acuamark Diagnostics (formerly iCareDx) develops technology which allows for highly accurate screening of blood to detect cancer markers at the early cancer stages, before the cancer becomes untreatable.